JP2006516191A5 - - Google Patents

Download PDF

Info

Publication number
JP2006516191A5
JP2006516191A5 JP2004555562A JP2004555562A JP2006516191A5 JP 2006516191 A5 JP2006516191 A5 JP 2006516191A5 JP 2004555562 A JP2004555562 A JP 2004555562A JP 2004555562 A JP2004555562 A JP 2004555562A JP 2006516191 A5 JP2006516191 A5 JP 2006516191A5
Authority
JP
Japan
Prior art keywords
tag
bflp
cell
region
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004555562A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006516191A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/037317 external-priority patent/WO2004047740A2/en
Publication of JP2006516191A publication Critical patent/JP2006516191A/ja
Publication of JP2006516191A5 publication Critical patent/JP2006516191A5/ja
Pending legal-status Critical Current

Links

JP2004555562A 2002-11-21 2003-11-21 ループス腎炎の治療用組成物および方法 Pending JP2006516191A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42806502P 2002-11-21 2002-11-21
PCT/US2003/037317 WO2004047740A2 (en) 2002-11-21 2003-11-21 Composition and method for treating lupus nephritis

Publications (2)

Publication Number Publication Date
JP2006516191A JP2006516191A (ja) 2006-06-29
JP2006516191A5 true JP2006516191A5 (enExample) 2007-01-18

Family

ID=32393343

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004555562A Pending JP2006516191A (ja) 2002-11-21 2003-11-21 ループス腎炎の治療用組成物および方法

Country Status (9)

Country Link
US (2) US20050119208A1 (enExample)
EP (1) EP1563056A4 (enExample)
JP (1) JP2006516191A (enExample)
CN (1) CN1738896A (enExample)
AU (1) AU2003295784B2 (enExample)
BR (1) BR0316467A (enExample)
CA (1) CA2504561A1 (enExample)
MX (1) MXPA05005284A (enExample)
WO (1) WO2004047740A2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020226960A1 (en) 2019-05-03 2020-11-12 Dicerna Pharmaceuticals, Inc. Double-stranded nucleic acid inhibitor molecules with shortened sense strands

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137077A1 (en) * 2000-10-25 2002-09-26 Hopkins Christopher M. Genes regulated in activated T cells
EP1661986A1 (en) * 2000-11-17 2006-05-31 Nuvelo, Inc. Nucleic acids and polypeptides enocoded thereby that are member of the kallikrein gene familyNovel nucleic acids and polypeptides
US6743619B1 (en) * 2001-01-30 2004-06-01 Nuvelo Nucleic acids and polypeptides
CA2445366A1 (en) * 2001-04-27 2002-11-21 Incyte Genomics, Inc. Molecules for disease detection and treatment
CA2500687A1 (en) * 2002-10-02 2004-04-15 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor

Similar Documents

Publication Publication Date Title
JP2005513162A5 (enExample)
JP2005120106A5 (enExample)
WO2006076410A3 (en) Li-key/antigenic epitope hybrid peptide vaccines
CY1106875T1 (el) Αντιγονικα πεπτιδια απο neisseria
ATE342359T1 (de) Design von beta-faltblatt-proteinen mit spezifischen bindungseigenschaften
CY1112833T1 (el) Καινοφανης προσδετης της κυτοκινης ζcυτοr17
NO20063026L (no) Antistoffer
KR960022559A (ko) 슈도모나스 에루지노사 막 단백질로부터 유도된 면역원성 하이브리드 단백질 OprF-Oprl
JP2004512815A5 (enExample)
EP0922055A4 (en) CONOTOXIN PEPTID PVIIA
EA200700973A1 (ru) Слитый белок, содержащий домен bh3 белка «вh3-только»
JP2003530357A5 (enExample)
JP2008521795A5 (enExample)
DK200601181A (da) Fiskevaccine
JP2006503088A5 (enExample)
RU2005126236A (ru) Фьюжн-белок для подавления цервикального рака
ATE408620T1 (de) Nichtimmunsuppressive immunogene oder vakzinzusammensetzung enthaltend ein mutiertes e7-protein vom humanen papilloma-virus hpv-16
ATE474589T1 (de) Angiogene peptide und ihre verwendungen
DE69229269D1 (de) Peptidfragmente des menschlichen cytochrome p450 iid6, antikörper dagegen und ihre verwendungen in diagnostik
JP2005512016A5 (enExample)
JP2008517998A5 (enExample)
JP2007516701A5 (enExample)
JP2006510360A5 (enExample)
JP2005535281A5 (enExample)
RU95116353A (ru) Способ получения нонапептидэтиламида